More powerful, lasting pain relief vs methylprednisolone acetate (MPA) in a Level I study.8
- DUROLANE was as effective as MPA at 6 weeks, measured by the WOMAC Pain responder rate.*8
- MPA reached maximum effect on mean WOMAC Pain scores at 6 weeks.8
- Results for WOMAC Pain, Physical Function and Stiffness scores trended in favour of DUROLANE from weeks 12 to 26 (end of study).8
WOMAC Pain scores (± 95% CIs) following double-blind treatment with either DUROLANE or MPA.
*Significant improvement from baseline with DUROLANE vs MPA at week 26 (p=0.034).
MPA, methylprednisolone acetate